IntroductionAs gene identification efforts have advanced in psychiatry. so have aspirations to use genome-wide polygenic information for prevention and intervention. Although polygenic risk scores (PRS) for substance use and psychiatric outcomes are not yet available in clinical settings. individuals can access their PRS through online direct-to-consumer resources. https://fitnessgravesyardes.shop/product-category/motor-contol-board/